Connect with us


Europe weighs risks, benefits of vaccinating kids against COVID-19



European countries are still deciding if and when to inoculate children against COVID-19 amid questions around safety, supply and the desperate call for more vaccines from hard-hit regions around the world.

After a sluggish rollout, inoculation programmes for the continent’s adults 16 years and up are now underway.

Adding children, who are less prone to severe COVID-19 but can be disease carriers, could help Europe to finally tame the pandemic.

Still, many health officials across Europe said they are continuing to weigh the low risk of serious COVID-19 disease among kids against the benefits for broader society that would accompany inoculating them.

“Individually, children and youth have less benefit from the vaccination than adults,” Norwegian Institute of Public Health infection control chief Geir Bukholm told Reuters.

“Vaccination to achieve herd immunity is also an aspect,” he added. “Should we recommend vaccination of children to gain control?”

In the United States, where more than 60% of adults have gotten at least one shot, 12- to 15-year olds started getting Pfizer/BioNTech shots this month.

Kids in Canada are getting shots, too.

The European Medicines Agency is still reviewing the Pfizer/ BioNTech for 12-to-15 year-olds, with Moderna planning to seek approval as early as next month.

In France, the reopening strategy likely must include vaccinating children, given its models require 90% of the population to get shots to avoid epidemic resurgence, its Institut Pasteur has said.

By May 20, however, only 18% of France’s adult population had received both shots of a coronavirus vaccine.

A source close to the French scientific committee that advises the government told Reuters its members are assessing several scenarios, including shots for 16-to-18 year-olds from June and younger children from September as the new school year starts.

“A clear answer from me is: ‘Maybe, and in any case, not now,” French Health Minister Olivier Veran said last week, when asked about vaccinating younger children.

“We need to get a shot to adults first.”

Italy could start by July, but the government is under pressure from a group of doctors and lawyers demanding a moratorium for children, due to what it calls a lack of long-term safety data.

“For children it is scientifically clear that there is no emergency,” Eugenio Serravalle, a pediatrician and president of the group, the Association of Health Studies and Information, told Reuters.


Initial clinical trials of the Pfizer and Moderna vaccines in children showed them to be very effective at preventing COVID-19, and found no new safety concerns, beyond side effects documented in adults, most commonly headache, fatigue, body aches and chills.

The U.S. Centers for Disease Control and Prevention is looking into reports that some young people have developed myocarditis, an inflammation of the heart muscle, after getting vaccinated.

In Switzerland, outside the European Union, federal officials hope to vaccinate 12- to 15-year olds starting this summer, pending regulatory approval.

While Britain’s speedy vaccination programme includes some 400,000 vaccinations daily and more than half of the population has been vaccinated, it has yet to decide on the under-16s, with the government saying it will be guided by the experts.

The prospect of children eventually rolling up their sleeves is already occupying thoughts of parents like Marie-Louise Pradin, a doctor in the northern French city of Lille with two boys, aged 11 and 14.

“The doctor in me tells me to go ahead, although I will admit the mother can’t help think: ‘What if…'” she said.

Meanwhile the World Health Organization has called for Western nations to delay vaccinating children and instead to donate doses to developing countries.

The low risk in children of suffering severe COVID-19 complications, combined with the desperate plight of nations like India struggling with fast-spreading variants and too little vaccine, mean there is a moral imperative for donations, said Georg Marckmann, a professor of medical ethics at Munich’s Ludwig Maxmilian University.

“There are good ethical reasons for Western countries to provide…vaccinations for low-income countries which have not been able to purchase sufficient dosages,” Marckmann said.

Still other experts counter that Western nations may be justified in inoculating their children before donating shots, as they aim for herd immunity and to eliminate excess deaths on the home front.

The virus has infected more than 32 million people and killed more than 712,000 in the 30-member European Economic Area (EEA).

Germany, where 13 percent of the adult population have received both doses of a vaccine, is debating now whether to give children from the age of 12 onwards shots from mid-June.

Its vaccine commission plans to make a decision in coming weeks.

“It must first be clarified exactly how urgently the children need the vaccination for their own health protection,” Chairman Thomas Mertens told German state radio on Tuesday.

“Our primary goal must be the protection and well-being of children.”


(Reporting by John Miller in Zurich, Matthias Blamont in Paris, Andreas Rinke and Maria Sheahan in Berlin, Emilio Parodi in Milan, Marine Stauss in Brussels, Tim Barsoe in Copenhagen, Essi Lehto in Helsinki, Terje Solsvik in Oslo, Alistair Smout in London, Gergely Szakacs in Budapest and Andrey Khalip in Lisbon; Editing by Josephine Mason and Raissa Kasolowsky)

Continue Reading


Biden’s vaccine pledge ups pressure on rich countries to give more



The United States on Thursday raised the pressure on other Group of Seven leaders to share their vaccine hoards to bring an end to the pandemic by pledging to donate 500 million doses of the Pfizer coronavirus vaccine to the world’s poorest countries.

The largest ever vaccine donation by a single country will cost the United States $3.5 billion but Washington expects no quid pro quo or favours for the gift, a senior Biden administration official told reporters.

U.S. President Joe Biden‘s move, on the eve of a summit of the world’s richest democracies, is likely to prompt other leaders to stump up more vaccines, though even vast numbers of vaccines would still not be enough to inoculate all of the world’s poor.

G7 leaders want to vaccinate the world by the end of 2022 to try to halt the COVID-19 pandemic that has killed more than 3.9 million people and devastated the global economy.

A senior Biden administration official described the gesture as a “major step forward that will supercharge the global effort” with the aim of “bringing hope to every corner of the world.” “We really want to underscore that this is fundamentally about a singular objective of saving lives,” the official said, adding that Washington was not seeking favours in exchange for the doses.

Vaccination efforts so far are heavily correlated with wealth: the United States, Europe, Israel and Bahrain are far ahead of other countries. A total of 2.2 billion people have been vaccinated so far out of a world population of nearly 8 billion, based on Johns Hopkins University data.

U.S. drugmaker Pfizer and its German partner BioNTech have agreed to supply the U.S. with the vaccines, delivering 200 million doses in 2021 and 300 million doses in the first half of 2022.

The shots, which will be produced at Pfizer’s U.S. sites, will be supplied at a not-for-profit price.

“Our partnership with the U.S. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible,” said Pfizer Chief Executive Albert Bourla.


Anti-poverty campaign group Oxfam called for more to be done to increase global production of vaccines.

“Surely, these 500 million vaccine doses are welcome as they will help more than 250 million people, but that’s still a drop in the bucket compared to the need across the world,” said Niko Lusiani, Oxfam America’s vaccine lead.

“We need a transformation toward more distributed vaccine manufacturing so that qualified producers worldwide can produce billions more low-cost doses on their own terms, without intellectual property constraints,” he said in a statement.

Another issue, especially in some poor countries, is the infrastructure for transporting the vaccines which often have to be stored at very cold temperatures.

Biden has also backed calls for a waiver of some vaccine intellectual property rights but there is no international consensus yet on how to proceed.

The new vaccine donations come on top of 80 million doses Washington has already pledged to donate by the end of June. There is also $2 billion in funding earmarked for the COVAX programme led by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), the White House said.

GAVI and the WHO welcomed the initiative.

Washington is also taking steps to support local production of COVID-19 vaccines in other countries, including through its Quad initiative with Japan, India and Australia.

(Reporting by Steve Holland in St. Ives, England, Andrea Shalal in Washington and Caroline Copley in Berlin; Writing by Guy Faulconbridge and Keith Weir;Editing by Leslie Adler, David Evans, Emelia Sithole-Matarise, Giles Elgood and Jane Merriman)

Continue Reading


Vaccines donated by the United States and China



Both the United States and China have pledged large donations of COVID-19 vaccines to countries around the world. Washington has promised 80 million doses, three-quarters of which will be delivered via the international vaccine initiative COVAX, in what has been seen as an effort to counter China’s widening vaccine diplomacy. It began deliveries last week.

China had shipped vaccines to 66 countries in the form of aid, according to state news agency Xinhua. Beijing has not disclosed an overall figure for its donations but Reuters calculations based on publicly available data show at least 16.57 million doses have been delivered. China has also pledged to supply 10 million doses to COVAX.

VACCINES DONATED BY U.S. (plan for the first 25 mln):

Regional partners and priority recipients


Including Canada, Mexico, 1 mln to S.Korea in June

South Korea, West Bank and

Gaza, Ukraine, Kosovo,

Haiti, Georgia, Egypt,

Jordan, India, Iraq, Yemen,

United Nations

TOTAL 6 mln 1 mln

Allocations through COVAX

South and Central America


Brazil, Argentina, Colombia,

Costa Rica, Peru, Ecuador,

Paraguay, Bolivia,

Guatemala, El Salvador,

Honduras, Panama, Haiti,

Dominican Republic and other

Caribbean Community

(CARICOM) countries

TOTAL 6 mln



India, Nepal, Bangladesh,

Pakistan, Sri Lanka,

Afghanistan, Maldives,

Malaysia, Philippines,

Vietnam, Indonesia,

Thailand, Laos, Papua New

Guinea, Taiwan, and the

Pacific Islands

TOTAL 7 mln



To be selected in

coordination with the

African Union

TOTAL 5 mln

VACCINES DONATED BY CHINA (source – Reuters calculations and official data):

Asia Pacific


Afghanistan 400,000

Bangladesh Second batch of First batch of 500,000 delivered

600,000 on May 12

Brunei 52,000 in Feb

Cambodia 1.7 mln as of April 28

Kyrgyzstan 150,000 in March

Laos 300,000 in Feb

800,000 in late March

300,000 in late April

Maldives 200,000 in early March

Mongolia 300,000 in late February

Myanmar 500,000 in early May

Nepal 800,000 in late March

1 mln in early June

Pakistan 500,000 in early Feb

250,000 in Feb

500,000 in March

Philippines 600,000 in late Feb

400,000 in late March

Sri Lanka 600,000 at end March

500,000 in late May

Thailand 500,000 in May

500,000 in June

Timor-Leste 100,000 100,000 in early June

TOTAL 11.052 million



Angola 200,000 in late March

Algeria 200,000 200,000 in Feb

Botswana 200,000 in April

Cameroon 200,000 in April

Congo 100,000 100,000 in March

Egypt 600,000 in March

Ethiopia 300,000 in late March

Equatorial Guinea 100,000 in Feb

Guinea 200,000 in early March

Mozambique 200,000 in late Feb

Namibia 100,000 by early April

Niger 400,000 in late March

Sierra Leone 240,000 by late May

Togo 200,000 in April

Uganda 300,000

Zimbabwe 200,000 in Feb

200,000 in March

100,000 in May

TOTAL 3.74 million

South America


Bolivia 100,000 in late Feb

100,000 in late March

Venezuela 500,000 in early March

TOTAL 700,000

Europe & Middle East


Belarus 100,000 in Feb

300,000 in May

Georgia 100,000 at end April

Iran 250,000 at end February

Iraq 50,000 in early March

Montenegro 30,000 in early March

North Macedonia 100,000 in May

Syria 150,000 in late April

TOTAL 1.08 million


(Reporting by Roxanne Liu and Ryan Woo in Beijing and Cooper Inveen in Dakar; Additional reporting by MacDonald Dzirutwe in Harare, Asif Shahzad in Islamabad, Gopal Sharma in Kathmandu; Editing by Edwina Gibbs)

Continue Reading


Coronavirus Worldwide right now



Here’s what you need to know about the coronavirus now:

Australia’s Melbourne to exit lockdown

Australia’s second largest city Melbourne will exit a hard lockdown as planned on Thursday night, Victoria state authorities said, although some restrictions on travel and gatherings would likely remain for another week.

After two weeks in a strict lockdown that forced people to remain at home except for essential business, Melbourne’s five million residents will get more freedom to step outside from 11:59 p.m. local time (1359 GMT) on Thursday.

However, people must stay within 25 km (15 miles) of their homes, officials said, in an effort to stop transmission during an upcoming long weekend. There will also be a total ban on house gatherings and masks will be mandatory indoors.

Deliveries of Thai-made AstraZeneca vaccines delayed

Malaysia and Taiwan are expecting deliveries of AstraZeneca vaccines manufactured in Thailand to be delayed, officials said, the latest countries to report a holdup with orders from the Thai plant.

The delay comes amid concerns over AstraZeneca’s distribution plans in Southeast Asia, which depends on 200 million doses made by Siam Bioscience, a company owned by Thailand’s king that is making vaccines for the first time.

Any questions about Siam Bioscience meeting production targets are sensitive because King Maha Vajiralongkorn is its sole owner. Insulting Thailand’s monarchy is a crime punishable by up to 15 years in prison.

Indonesia aims to speed up vaccinations

President Joko Widodo said on Wednesday he hoped Indonesia’s vaccination rollout will hit one million shots a day by July, as authorities opened up inoculations to anyone aged over 18 in Jakarta to contain increased transmission in the capital.

Health officials in the world’s fourth most populous country, which aims to vaccinate 181.5 million people by next year, are trying to speed up the rollout after facing some supply issues.

The president said he wanted vaccinations to hit a targeted 700,000 doses a day this month and then rise again.

Singapore finds Delta most prevalent among variants

Singapore has found the Delta variant of the coronavirus to be the most prevalent among local cases of variants of concern (VOCs), according to health ministry data, highlighting its level of infectiousness.

There were 449 local cases with VOCs as of May 31, of which 428 were the Delta variant first detected in India and nine of the Beta variant first identified in South Africa.

Singapore reported its 34th death due to COVID-19, taking its toll from the pandemic beyond the 33 casualties recorded during the 2003 Severe Acute Respiratory Syndrome outbreak.

U.S. forming expert groups on lifting travel restrictions

The Biden administration is forming expert working groups with Canada, Mexico, the European Union and the United Kingdom to determine how best to safely restart travel after 15 months of pandemic restrictions, a White House official said on Tuesday.

Another U.S. official said the administration will not move quickly to lift orders that bar people from much of the world from entering the United States because of the time it will take for the groups to do their work.

The groups will be led by the White House COVID Response Team and the National Security Council and include the Centers for Disease Control and other U.S. agencies.


(Compiled by Linda Noakes; Editing by Giles Elgood)

Continue Reading